SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Resveratrol may protect against metabolic disease through activating SIRT1 deacetylase. Because we have recently defined AMPK activation as a key mechanism for the beneficial effects of polyphenols on hepatic lipid accumulation, hyperlipidemia, and atherosclerosis in type 1 diabetic mice, we hypothesize that polyphenol-activated SIRT1 acts upstream of AMPK signaling and hepatocellular lipid metabolism. Here we show that polyphenols, including resveratrol and the synthetic polyphenol S17834, increase SIRT1 deacetylase activity, LKB1 phosphorylation at Ser(428), and AMPK activity. Polyphenols substantially prevent the impairment in phosphorylation of AMPK and its downstream target, ACC (acetyl-CoA carboxylase), elevation in expression of FAS (fatty acid synthase), and lipid accumulation in human HepG2 hepatocytes exposed to high glucose. These effects of polyphenols are largely abolished by pharmacological and genetic inhibition of SIRT1, suggesting that the stimulation of AMPK and lipid-lowering effect of polyphenols depend on SIRT1 activity. Furthermore, adenoviral overexpression of SIRT1 stimulates the basal AMPK signaling in HepG2 cells and in the mouse liver. AMPK activation by SIRT1 also protects against FAS induction and lipid accumulation caused by high glucose. Moreover, LKB1, but not CaMKKbeta, is required for activation of AMPK by polyphenols and SIRT1. These findings suggest that SIRT1 functions as a novel upstream regulator for LKB1/AMPK signaling and plays an essential role in the regulation of hepatocyte lipid metabolism. Targeting SIRT1/LKB1/AMPK signaling by polyphenols may have potential therapeutic implications for dyslipidemia and accelerated atherosclerosis in diabetes and age-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SIRT1 crosstalks with the mTOR and AMPK pathways by interacting with hamartin–tuberin and deacetylating LKB1”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
Cited by
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,778
“It is likely that other nutrient sensors controlled by AMPK, such as downstream kinases like mTORC1, or concurrent regulation of SIRT1 and AMPK (Hou et al., 2008), may also modulate SREBP-dependent lipid synthesis in type 2 diabetes.”
Self-citationPrice, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602
“Alternatively, resveratrol may first activate SIRT1 in vivo, leading to AMPK activation via deacetylation and activation of the AMPK kinase LKB1 (Hou et al., 2008; Ivanov et al., 2008; Lan et al., 2008).”
BackgroundAMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Zhang, B. B., Zhou, G., & Li, C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.012 · Cited by 1,026
“In parallel, SIRT1 activation by resveratrol and the synthetic polyphenol S17834, while increasing SIRT1 deacetylase activity, also increased LKB1 phosphorylation at Ser428 and AMPK activity (Hou et al., 2008).”
BackgroundAMPK and SIRT1: a long-standing partnership?
Ruderman, N. B., Julia Xu, X., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F., & Ido, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00745.2009 · Cited by 903
Self-citationAMPK, insulin resistance, and the metabolic syndrome
Ruderman, N. B., Carling, D., Prentki, M., & Cacicedo, J. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67227 · Cited by 873
Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds
Bonkowski, M. S., & Sinclair, D. A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.93 · Cited by 834
SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1
Lan, F., Cacicedo, J. M., Ruderman, N., & Ido, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805711200 · Cited by 825
Self-citationLuen Tang, B. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2318 · Cited by 740
“That Sirt1 may act upstream of AMPK has support in a previous report, which showed that Sirt1 could potentially deacetylate and activate the major AMPK activating kinase, Serine/threonine kinase 11 (STK11) (or liver kinase B1, LKB1) (Lan et al., 2008).”
BackgroundSirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism
Nogueiras, R., Habegger, K. M., Chaudhary, N., Finan, B., Banks, A. S., Dietrich, M. O., Horvath, T. L., Sinclair, D. A., Pfluger, P. T., & Tschöp, M. H. (2012) · Physiological Reviews · doi:10.1152/physrev.00022.2011 · Cited by 711
“On the other hand, SIRT1 regulates LKB1, an upstream regulator of AMPK (140, 386).”
BackgroundInfluentialFeige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J., & Auwerx, J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.017 · Cited by 719
“It is possible that the recently described SIRT1-dependent regulation of LKB1 plays a role in this regulation (Hou et al., 2008).”
BackgroundRegulation of SIRT1 in cellular functions: Role of polyphenols
Chung, S., Yao, H., Caito, S., Hwang, J.-W., Arunachalam, G., & Rahman, I. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.003 · Cited by 650
Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J. E., Janle, E. M., Lobo, J., Ferruzzi, M. G., Davies, P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060061 · Cited by 645
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., & Chung, J. H. (2010) · Diabetes · doi:10.2337/db09-0482 · Cited by 647
“Whether it is the direct target of resveratrol or not, it appears that Sirt1 can also function upstream of AMPK in HepG2 hepatocytes and HEK293T cell line (26,27).”
BackgroundSimcox, J. A., & McClain, D. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.007 · Cited by 545
“…understood, plausible candidates include:(1) alterations in AMP/ATP ratios caused by iron-induced mitochondrial dysfunction (Jouihan et al., 2008), or (2) stimulation of the upstream activating kinase of AMPK, LKB1, by SIRT1-mediated deacetylation (Hou et al., 2008; Lan et al., 2008).”
BackgroundCancer chemoprevention by dietary polyphenols: Promising role for epigenetics
Link, A., Balaguer, F., & Goel, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.036 · Cited by 497
Viollet, B., Guigas, B., Leclerc, J., Hébrard, S., Lantier, L., Mounier, R., Andreelli, F., & Foretz, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01970.x · Cited by 486
“It has been demonstrated that SIRT1 activation by resveratrol functions as an upstream regulator in the LKB1/ AMPK signalling axis (Hou et al. 2008).”
BackgroundAutophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
AMPK and the biochemistry of exercise: implications for human health and disease
Richter, E. A., & Ruderman, N. B. (2009) · Biochemical Journal · doi:10.1042/bj20082055 · Cited by 481
“Recent reports suggest that SIRT1 may function, at least in part by activating AMPK [71;71;225]; indeed, resveratrol, which was used in some of the above mentioned rodent studies [3;6] has clearly been demonstrated to activate AMPK in various tissues and cells [6;225].”
BackgroundThe molecular targets of resveratrol
Kulkarni, S. S., & Cantó, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.005 · Cited by 477
“For example, Rsv required AMPK in order to decrease lipid accumulation in HepG2 cells [75].”
BackgroundCalorie restriction and sirtuins revisited
Guarente, L. (2013) · Genes & Development · doi:10.1101/gad.227439.113 · Cited by 464
“SIRT1 and eNOS may comprise a mutually reinforcing activity loop, as for SIRT1 and AMPK.”
BackgroundInfluentialAMPK activation: a therapeutic target for type 2 diabetes?
Saha, A., Coughlan, K., Valentine, R., & Ruderman, N. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s43731 · Cited by 429
Hormonal regulation of hepatic glucose production in health and disease
Lin, H. V., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.003 · Cited by 429
“…of hepatic glucose metabolism in liver-specific Sirt1 knockouts are unremarkable (Chen et al., 2008), but this might reflect opposing effects of other Sirt1-dependent processes, such as CRTC2 degradation (Liu et al., 2008), SHP induction (Wei et al., 2011), and AMPK activation (Hou et al., 2008).”
BackgroundCapiralla, H., Vingtdeux, V., Zhao, H., Sankowski, R., Al‐Abed, Y., Davies, P., & Marambaud, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07594.x · Cited by 426
“Moreover, SIRT1 activation by resveratrol can lead to AMPK activation in several cell lines, including HepG2 hepatocytes and HEK293T cells (Hou et al. 2008; Lan et al. 2008).”
BackgroundAMP-activated protein kinase and its downstream transcriptional pathways
Cantó, C., & Auwerx, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0454-z · Cited by 421
“might reciprocally activate each other in liver and HepG2 cells [16, 164, 165], creating a positive”
BackgroundYang, X., Xu, S., Qian, Y., & Xiao, Q. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.03.003 · Cited by 413
“A major pathway seems to involve silent information regulator-1 (SIRT1), SIRT1 can promote Th2 responses by increasing anti-inflammatory cytokine expression (Hou et al., 2008; Nimmagadda et al., 2013).”
Self-citationYang, Z., Kahn, B. B., Shi, H., & Xue, B.-Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123620 · Cited by 410
Caloric restriction, SIRT1 and longevity
Cantó, C., & Auwerx, J. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.03.008 · Cited by 395
“While some groups have reported that resveratrol action on AMPK is SIRT1 dependent [99, 100], other groups, as well as unpublished data from our lab, suggest that, at least in certain cell types, SIRT1 is dispensable for resveratrol-induced AMPK-activation [97, 101].”
Are sirtuins viable targets for improving healthspan and lifespan?
Baur, J. A., Ungvari, Z., Minor, R. K., Le Couteur, D. G., & de Cabo, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3738 · Cited by 382
Rivera, L., Morón, R., Zarzuelo, A., & Galisteo, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.027 · Cited by 391
Resveratrol alleviates alcoholic fatty liver in mice
Ajmo, J. M., Liang, X., Rogers, C. Q., Pennock, B., & You, M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90358.2008 · Cited by 314
Resveratrol and diabetes: from animal to human studies
Szkudelski, T., & Szkudelska, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.013 · Cited by 354
Kawai, Y., Garduño, L., Theodore, M., Yang, J., & Arinze, I. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208173 · Cited by 353
Li, X. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms108 · Cited by 360
Liang, F., Kume, S., & Koya, D. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.101 · Cited by 357
“However, overexpression of SIRT1 stimulates basal AMP-activated protein kinase in cultured hepatocytes (HepG2 cells) and in the mouse liver, which protects against fatty-acid synthase induction and lipid accumulation caused by hyperglycemia”
BackgroundWalker, A. K., Yang, F., Jiang, K., Ji, J.-Y., Watts, J. L., Purushotham, A., Boss, O., Hirsch, M. L., Ribich, S., Smith, J. J., et al. (2010) · Genes & Development · doi:10.1101/gad.1901210 · Cited by 357
“2010), at least in mammalian contexts (Hou et al. 2008; Canto et al. 2009), andmay thus act as an upstream fasting-regulated signal transducer to coordinately regulate multiple facets of lipogenesis, including SIRT1-dependent control of SREBPs.”
BackgroundDevelopment of protein kinase activators: AMPK as a target in metabolic disorders and cancer
Fogarty, S., & Hardie, D. G. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.012 · Cited by 350
Sirtuins mediate mammalian metabolic responses to nutrient availability
Chalkiadaki, A., & Guarente, L. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.225 · Cited by 346
SIRT4 Regulates Fatty Acid Oxidation and Mitochondrial Gene Expression in Liver and Muscle Cells
Nasrin, N., Wu, X., Fortier, E., Feng, Y., Bare', O. C., Chen, S., Ren, X., Wu, Z., Streeper, R. S., & Bordone, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.124164 · Cited by 322
Srivastava, R. A. K., Pinkosky, S. L., Filippov, S., Hanselman, J. C., Cramer, C. T., & Newton, R. S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r025882 · Cited by 296
“Overexpression of SIRT1 increased, while shRNA silencing of SIRT1 dramatically decreased LKB1, AMPK and ACC phosphorylation, and glucose stimulated triglyceride accumulation (91), suggesting an important role of AMPK- SIRT1 axis in hepatic lipid metabolism.”
BackgroundLi, Y., Xu, S., Giles, A., Nakamura, K., Lee, J. W., Hou, X., Donmez, G., Li, J., Luo, Z., Walsh, K., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-173492 · Cited by 297
“We and others recently demonstrate that SIRT1 activation by resveratrol stimulates AMPK activity through deacetylation and activation of LKB1 in cultured cells and in mouse livers (17, 49).”
BackgroundSelf-citationmTORC1 and SIRT1 Cooperate to Foster Expansion of Gut Adult Stem Cells during Calorie Restriction
Igarashi, M., & Guarente, L. (2016) · Cell · doi:10.1016/j.cell.2016.05.044 · Cited by 305
“ADcrypts of Sir2d mice also showed increased AMPK phosphorylation (Figure 4E), likely due to the known the activation of the other known AMPK kinase, LKB1, by SIRT1-mediated deacetylation (Hou et al., 2008; Lan et al., 2008).”
Zu, Y., Liu, L., Lee, M. Y. K., Xu, C., Liang, Y., Man, R. Y., Vanhoutte, P. M., & Wang, Y. (2010) · Circulation Research · doi:10.1161/circresaha.109.215483 · Cited by 303
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Chachay, V. S., Macdonald, G. A., Martin, J. H., Whitehead, J. P., O'Moore–Sullivan, T. M., Lee, P., Franklin, M., Klein, K., Taylor, P. J., Ferguson, M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.024 · Cited by 289
“The mechanism of resveratrol on lipid metabolism has been proposed via activation of AMPK, SIRT1, and the resulting increased fat-oxidation.(51) The lipolytic activity of resveratrol has also been reported in human adipocytes via regulation of adipose triglyceride lipase.”
BackgroundActivation and Signaling by the AMP-Activated Protein Kinase in Endothelial Cells
Fisslthaler, B., & Fleming, I. (2009) · Circulation Research · doi:10.1161/circresaha.109.201590 · Cited by 295
PGC-1α and PGC-1Β Regulate Mitochondrial Density in Neurons
Wareski, P., Vaarmann, A., Choubey, V., Safiulina, D., Liiv, J., Kuum, M., & Kaasik, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018911 · Cited by 294
Sirtuin 1 in lipid metabolism and obesity
Schug, T. T., & Li, X. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.547211 · Cited by 292
“Additionally, SIRT1 acts downstream of AMPK signaling, promoting fatty acid catabolism (58).”
BackgroundResveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases
Pannu, N., & Bhatnagar, A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.075 · Cited by 281
Targeting the AMPK pathway for the treatment of Type 2 diabetes
Viollet, B. (2009) · Frontiers in Bioscience · doi:10.2741/3460 · Cited by 278
“Furthermore, it has been demonstrated that SIRT1 functions as an upstream regulator of the LKB1/AMPK signaling axis in response to RSV activation in hepatocytes (98).”
Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition
Park, D., Jeong, H., Lee, M. N., Koh, A., Kwon, O., Yang, Y. R., Noh, J., Suh, P.-G., Park, H., & Ryu, S. H. (2016) · Scientific Reports · doi:10.1038/srep21772 · Cited by 281
Li, Y., Wong, K., Giles, A., Jiang, J., Lee, J. W., Adams, A. C., Kharitonenkov, A., Yang, Q., Gao, B., Guarente, L., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.059 · Cited by 279
“hepatic SIRT1 is required for fasting-induced production and secretion of FGF21 in the liver; (2) defective FGF21 caused by hepatic SIRT1 ablation exacerbates fasting-induced hepatic steatosis by impairing fatty acid oxidation and increasing lipogenesis; (3) FGF21 is essential for SIRT1 to stimulate hepatocyte fatty a…”
BackgroundSelf-citationShear stress, SIRT1, and vascular homeostasis
Chen, Z., Peng, I.-C., Cui, X., Li, Y.-S., Chien, S., & Shyy, J. Y.-J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003833107 · Cited by 281
“Depending on the stimuli, AMPK and SIRT1 can regulate each other reciprocally (23, 24).”
BackgroundImpairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation
Bruning, U., Morales-Rodriguez, F., Kalucka, J., Goveia, J., Taverna, F., Queiroz, K. C. S., Dubois, C., Cantelmo, A. R., Chen, R., Loroch, S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.019 · Cited by 282
Zelber‐Sagi, S., Salomone, F., & Mlynarsky, L. (2017) · Liver International · doi:10.1111/liv.13435 · Cited by 273
Lee, J., Padhye, A., Sharma, A., Song, G., Miao, J., Mo, Y.-Y., Wang, L., & Kemper, J. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094524 · Cited by 263
Kitada, M., Ogura, Y., & Koya, D. (2016) · Aging · doi:10.18632/aging.101068 · Cited by 270
Ding, J., Li, M., Wan, X., Jin, X., Chen, S., Yu, C., & Li, Y. (2015) · Scientific Reports · doi:10.1038/srep13729 · Cited by 261
SIRT1: recent lessons from mouse models
Herranz, D., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2962 · Cited by 255
Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes
Cantó, C., Sauve, A. A., & Bai, P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.004 · Cited by 246
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt
Chan, A. Y. M., Dolinsky, V. W., Soltys, C.-L. M., Viollet, B., Baksh, S., Light, P. E., & Dyck, J. R. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802869200 · Cited by 244
Chen, J., Liu, B., Yao, X., Yang, X., Sun, J., Yi, J., Xue, F., Zhang, J., Shen, Y., Chen, B., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70657 · Cited by 190
“For tau pathology modulation, SIRT1-mediated Tau deacetylation effectively prevents its hyperphosphorylation and subsequent neurofibrillary tangle formation [86, 87].”
Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK
Zygmunt, K., Faubert, B., MacNeil, J., & Tsiani, E. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.048 · Cited by 222
Small-Molecule Allosteric Activators of Sirtuins
Sinclair, D. A., & Guarente, L. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134657 · Cited by 223
“Several papers showed that resveratrol can activate AMPK in vivo (88, 107, 108), leading some researchers to speculate that resveratrol indirectly activates SIRT1 via AMPK.”
BackgroundMolecular mechanisms of the cardiovascular protective effects of polyphenols
Andriantsitohaina, R., Auger, C., Chataigneau, T., Étienne-Selloum, N., Li, H., Martínez, M. C., Schini-Kerth, V. B., & Laher, I. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512003406 · Cited by 213
“It is likely that SIRT1 may be upstream of AMPK, since SIRT1 activation increases AMPK activity((168)), probably by SIRT1 deacetylation/activation of the upstream AMPK kinase liver kinase B1 (LKB1)((169)).”
BackgroundMetformin modulates hyperglycaemia‐induced endothelial senescence and apoptosis through SIRT1
Arunachalam, G., Samuel, S. M., Marei, I., Ding, H., & Triggle, C. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12496 · Cited by 221
“AMPK positively regulates SIRT1 expression by elevating the intracellular levels of its co-substrate NAD+ while SIRT1 activation leads to AMPK activation via deacetylation and activation of the AMPK, LKB-1 (Hou et al., 2008; Canto et al., 2009).”
BackgroundInfluentialStimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK
Breen, D. M., Sanli, T., Giacca, A., & Tsiani, E. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.104 · Cited by 213
Shen, Z., Liang, X., Rogers, C. Q., Rideout, D., & You, M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00456.2009 · Cited by 214
“There is accumulating evidence that SIRT1 and AMPK regulate each other’s activity (6, 7, 15, 17, 32, 40).”
Resveratrol and Vascular Function
Li, H., Xia, N., Hasselwander, S., & Daiber, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092155 · Cited by 203
“, by reduction of the intracellular ATP level [17,18] or its deacetylation by SIRT1 [19,20].”
BackgroundResveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice
Mancuso, R., del Valle, J., Modol, L., Martinez, A., Granado-Serrano, A. B., Ramirez-Núñez, O., Pallás, M., Portero-Otin, M., Osta, R., & Navarro, X. (2014) · Neurotherapeutics · doi:10.1007/s13311-013-0253-y · Cited by 206
“Alternatively, resveratrol may first activate Sirt1, leading to AMPK activation via deacetylation and activation of the AMPK kinase LKB1 [20, 21].”
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5
Caton, P. W., Nayuni, N. K., Kieswich, J., Khan, N. Q., Yaqoob, M. M., & Corder, R. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0345 · Cited by 198
“Recent studies have reported that SIRT1 can deacetylate and activate LKB1, leading to the activation of AMPK (Hou et al. 2008, Lan et al. 2008).”
BackgroundZhao, H., Chen, S., Gao, K., Zhou, Z., Wang, C., Shen, Z., Guo, Y., Li, Z., Wan, Z., Liu, C., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.027 · Cited by 202
Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells
Kim, T., Davis, J., Zhang, A. J., He, X., & Mathews, S. T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.018 · Cited by 194
Chini, E. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787185788 · Cited by 189
“In cultured hepatocytes, SIRT1 inhibits glucose induced cellular fat accumulation via an AMPK dependent mechanism [65, 66].”
BackgroundShin, S. M., Cho, I. J., & Kim, S. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058479 · Cited by 195
Targeting Mitochondrial Biogenesis with Polyphenol Compounds
Chodari, L., Dilsiz Aytemir, M., Vahedi, P., Alipour, M., Vahed, S. Z., Khatibi, S. M. H., Ahmadian, E., Ardalan, M., & Eftekhari, A. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4946711 · Cited by 193
Derdak, Z., Villegas, K. A., Harb, R., Wu, A. M., Sousa, A., & Wands, J. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.042 · Cited by 193
“suppressor of fatty acid synthesis and activator of fatty acid oxidation [14-16, 19].”
Hypothalamic Sirt1 Regulates Food Intake in a Rodent Model System
Çakir, I., Perello, M., Lansari, O., Messier, N. J., Vaslet, C. A., & Nillni, E. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008322 · Cited by 194
“It was recently reported that Sirt1 and AMPK could activate each other [37,38,39].”
BackgroundQuercetin's Influence on Exercise Performance and Muscle Mitochondrial Biogenesis
NIEMAN, D. C., WILLIAMS, A. S., SHANELY, R. A., JIN, F., MCANULTY, S. R., TRIPLETT, N. T., AUSTIN, M. D., & HENSON, D. A. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181b18fa3 · Cited by 194
Resveratrol as a calorie restriction mimetic: therapeutic implications
Chung, J. H., Manganiello, V., & Dyck, J. R. B. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.07.004 · Cited by 192
An Acetylation Switch Modulates the Transcriptional Activity of Estrogen-Related Receptor α
Wilson, B. J., Tremblay, A. M., Deblois, G., Sylvain-Drolet, G., & Giguère, V. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0441 · Cited by 192
Saha, A. K., Xu, X. J., Lawson, E., Deoliveira, R., Brandon, A. E., Kraegen, E. W., & Ruderman, N. B. (2010) · Diabetes · doi:10.2337/db09-1870 · Cited by 187
“This in turn was associated with a 20% decrease in the abundance of the NADdependent histone/protein deacetylase SIRT1, an enzyme reported to deacetylate the AMPK kinase LKB1 leading to an increase in its activity and that of AMPK (29-31).”
BackgroundEscande, C., Chini, C. C. S., Nin, V., Dykhouse, K. M., Novak, C. M., Levine, J., van Deursen, J., Gores, G. J., Chen, J., Lou, Z., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39319 · Cited by 183
The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis
Sosnowska, B., Mazidi, M., Penson, P., Gluba-Brzózka, A., Rysz, J., & Banach, M. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.08.027 · Cited by 187
“Natural products such as resveratrol, genistein, quercetin, berberine, curcumin, delphinidin-3-glucoside and ginkgolide B may be harder to investigate robustly owing to difficulties in measuring dietary intake in observa tional studies and because of the difficulty in eli minating variability between batches of supple…”
BackgroundSIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL
Chakrabarti, P., English, T., Karki, S., Qiang, L., Tao, R., Kim, J., Luo, Z., Farmer, S. R., & Kandror, K. V. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014647 · Cited by 179
Manna, P., Achari, A. E., & Jain, S. K. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.01.002 · Cited by 181
Hepatic Suppression of Foxo1 and Foxo3 Causes Hypoglycemia and Hyperlipidemia in Mice
Zhang, K., Li, L., Qi, Y., Zhu, X., Gan, B., DePinho, R. A., Averitt, T., & Guo, S. (2012) · Endocrinology · doi:10.1210/en.2011-1527 · Cited by 179
“5 mM glucose overnight and then treated with 30 mM high glucose for 24 h, a condition that promotes lipid synthesis in cells (30, 31).”
BackgroundMethodSIRT1 and AMPK in regulating mammalian senescence: A critical review and a working model
Wang, Y., Liang, Y., & Vanhoutte, P. M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.11.047 · Cited by 177
“trol activates LKB1/AMPK signaling in both SIRT1-dependent and independent manners in HepG2 cells [95,175].”
BackgroundPfister, J. A., Ma, C., Morrison, B. E., & D'Mello, S. R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004090 · Cited by 178
La Merrill, M., Karey, E., Moshier, E., Lindtner, C., La Frano, M. R., Newman, J. W., & Buettner, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103337 · Cited by 176
“wild type mice, and all other antibodies have been characterized and validated in prior peer review publications [(Table S1), [37–41]].”
BackgroundRupasinghe, H. P. V., Sekhon-Loodu, S., Mantso, T., & Panayiotidis, M. I. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.005 · Cited by 171
“Its major role is played in hepatic fatty 127 acid metabolism, at various steps such as activation of the AMPK/LKB1 pathway thus 128 facilitating fatty acid oxidation (Hou et al., 2008).”
Suter, M. A., Chen, A., Burdine, M. S., Choudhury, M., Harris, R. A., Lane, R. H., Friedman, J. E., Grove, K. L., Tackett, A. J., & Aagaard, K. M. (2012) · The FASEB Journal · doi:10.1096/fj.12-212878 · Cited by 171
Feillet-Coudray, C., Sutra, T., Fouret, G., Ramos, J., Wrutniak-Cabello, C., Cabello, G., Cristol, J. P., & Coudray, C. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.11.020 · Cited by 173
Luo, T., Nocon, A., Fry, J., Sherban, A., Rui, X., Jiang, B., Xu, X. J., Han, J., Yan, Y., Yang, Q., et al. (2016) · Diabetes · doi:10.2337/db15-1122 · Cited by 172
“Stimulation of fat AMPK activity was further confirmed by concomitantly increased Ser79 phosphorylation of acetyl-CoA carboxylase (ACC), a wellknown substrate of AMPK, consistent with metformininduced AMPK in insulin-resistant cells (6,7,34) and in the livers of diabetic mice (8,35).”
BackgroundMethodSelf-citationShen, Z., Ajmo, J. M., Rogers, C. Q., Liang, X., Le, L., Murr, M. M., Peng, Y., & You, M. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00016.2009 · Cited by 172
“Sirtuin activity was measured by a SIRT1 fluorometric kit (AK-555, Biomol, Plymouth Meeting, PA) (14, 38).”
MethodCalorie restriction and resveratrol in cardiovascular health and disease
Dolinsky, V. W., & Dyck, J. R. B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.010 · Cited by 168
Resveratrol and Endothelial Nitric Oxide
Xia, N., Förstermann, U., & Li, H. (2014) · Molecules · doi:10.3390/molecules191016102 · Cited by 163
“In addition, resveratrol has been shown to activate AMPK through SIRT1-mediated deacetylation and activation of LKB1 in hepatocytes and muscle cells [41,42].”
BackgroundVetterli, L., Brun, T., Giovannoni, L., Bosco, D., & Maechler, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.176842 · Cited by 165
PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
Sen, N., Satija, Y. K., & Das, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.044 · Cited by 166
“In our experimental system we did not see a robust induction of endogenous Sirt1 levels upon glucose deprivation, as has been previously reported (Hou et al., 2008; Pang et al., 2011), and could not detect its interaction with p53.”
AMPK at the crossroads of circadian clocks and metabolism
Jordan, S. D., & Lamia, K. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.017 · Cited by 162
“, 2008) and activation of SIRT1 may cause AMPK phosphorylation via deacetylation-dependent activation of the AMPK-activating kinase liver kinase B1 (LKB1) (Hou et al., 2008; Lan et al., 2008).”
InfluentialMicroRNA-217 Promotes Ethanol-induced Fat Accumulation in Hepatocytes by Down-regulating SIRT1
Yin, H., Hu, M., Zhang, R., Shen, Z., Flatow, L., & You, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.333534 · Cited by 162
“SIRT1 regulates AMPK activity, and ethanol causes fat accumulation by inhibition of AMPK in hepatocytes (21, 22).”
BackgroundEpigenetic Regulatory Mechanisms Induced by Resveratrol
Fernandes, G., Silva, G., Pavan, A., Chiba, D., Chin, C., & Dos Santos, J. (2017) · Nutrients · doi:10.3390/nu9111201 · Cited by 161
“Hou and collaborators report that RVT was able to increase AMP-activated protein kinase (AMPK) activity by activating SIRT1, which in turn led to a reduction in its downstream targets, such as ACC (acetyl-CoA carboxylase), FAS (fatty acid synthase) expression and lipid accumulation in human HepG2 hepatocytes exposed t…”
Background
Metadata
- Authors
- Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T. J., Cohen, R. A., & Zang, M.
- Affiliations
- Boston University (US)
- Institut de Recherches Internationales Servier (France) (FR)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 283
- Issue
- 29
- Pages
- 20015-20026
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2459285
- OpenAlex
- W1973163466
- Cited by
- 778
- References
- 57
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 26 · 2023: 29 · 2022: 38 · 2021: 33 · 2020: 38 · 2019: 42 · 2018: 52 · 2017: 49 · 2016: 50 · 2015: 50 · 2014: 60 · 2013: 71 · 2012: 54
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4458 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Servier
- National Institutes of Health (P01 HL 68758)
- Institut de Recherches Servier
- National Institute on Aging (R01 AG-27080, R01AG027080)
- National Heart, Lung, and Blood Institute (P01HL068758, P01-HL68758)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK 76942, R01DK076942)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- SIRT1, AMPK, LKB1, polyphenols, resveratrol, hepatocyte lipid metabolism, hepatic lipid accumulation, fatty acid synthase, acetyl-CoA carboxylase, high glucose, dyslipidemia, atherosclerosis, type 1 diabetes, CaMKKβ
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Animals, Cell Line, Enzyme Activation, Flavonoids, Glucose, Humans, Multienzyme Complexes, Phenols, Signal Transduction, Gene Expression Regulation, Enzymologic, Protein Serine-Threonine Kinases, Hepatocytes, RNA Interference, Sirtuins, Lipid Metabolism, Mice, Focal Adhesion Protein-Tyrosine Kinases, Calcium-Calmodulin-Dependent Protein Kinase Kinase, AMP-Activated Protein Kinases, Sirtuin 1, Polyphenols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.